Literature DB >> 1371551

The intraprostatic spiral: clinical results in 150 consecutive patients.

J Nordling1, H Ovesen, A L Poulsen.   

Abstract

The clinical results of treatment of infravesical prostatic obstruction with an intraurethral coil in 150 consecutive patients are reported. A total of 80 patients had urinary retention and 70 had severe prostatism. Median observation time was 8.2 months, with a range of 0 to 40 months. In 75 patients the spiral was removed after a median of 4 months (range 0 to 30 months) because of planned prostatectomy in 17, urinary retention in 16, incontinence in 10, local discomfort in 7, no symptomatic improvement in 13 and causes not related to the spiral (stroke and so forth) in 7. Migration occurred 55 times in 42 patients but this only led to coil removal in 5. A total of 23 patients died with the coil in situ. Voiding symptoms improved considerably in the majority of the patients. Approximately two-thirds of the patients had no or few symptoms, while a fourth had moderate symptoms, leaving only approximately 10% with severe prostatism. Chronic bacteriuria was noted in 52 patients but was not a clinical problem. Calcification on the top and inside of the coil was noted mainly after long-term treatment, and probably necessitated exchange of the coil after 2 to 3 years. We conclude that the prostatic spiral is a useful alternative to an indwelling catheter. However, life-long followup is necessary in most patients.

Entities:  

Mesh:

Year:  1992        PMID: 1371551     DOI: 10.1016/s0022-5347(17)37333-0

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  5 in total

Review 1.  Biocompatible Polymer Materials with Antimicrobial Properties for Preparation of Stents.

Authors:  Kateřina Škrlová; Kateřina Malachová; Alexandra Muñoz-Bonilla; Dagmar Měřinská; Zuzana Rybková; Marta Fernández-García; Daniela Plachá
Journal:  Nanomaterials (Basel)       Date:  2019-10-31       Impact factor: 5.076

2.  Thermo-expandable intra-prostatic stent in the treatment of acute urinary retention in elderly patients with significant co-morbidities.

Authors:  G Lee; S Marathe; S Sabbagh; J Crisp
Journal:  Int Urol Nephrol       Date:  2005       Impact factor: 2.266

3.  An analysis of the costs of alternative treatments for benign prostatic hypertrophy.

Authors:  J A Vale; A S Bdesha; R O Witherow
Journal:  J R Soc Med       Date:  1995-11       Impact factor: 18.000

Review 4.  Use of prostatic stents for the treatment of benign prostatic hyperplasia in high-risk patients.

Authors:  J S Lam; M A Volpe; S A Kaplan
Journal:  Curr Urol Rep       Date:  2001-08       Impact factor: 2.862

5.  Temporary prostatic stenting and androgen suppression: a new minimally invasive approach to malignant prostatic retention.

Authors:  K M Anson; D G Barnes; T P Briggs; G M Watson; R A Miller
Journal:  J R Soc Med       Date:  1993-11       Impact factor: 18.000

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.